Breaking News
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - New model more effective in predicting risk of opioid overdose than traditional models
March 22, 2019 - Mayo Clinic study identifies potential new drug therapy for liver diseases
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
March 22, 2019 - Stroke risk reduces in both black and white older Medicare beneficiaries, study reports
March 22, 2019 - City of Hope exhibits current studies and data on cancer therapies at AACR
March 22, 2019 - New study identifies CD40 molecule as key entry point for dangerous bacteria
March 22, 2019 - Health Tip: Six Steps to a Healthier Life
March 22, 2019 - even a little activity helps you live longer
March 22, 2019 - Many individuals recovering from addiction continue to suffer from chronic physical disease
March 22, 2019 - New drugs on PBS for Parkinson’s, MND and Cutaneous T cell lymphoma
March 22, 2019 - Saving energy also saves lives, UW-Madison study says
March 22, 2019 - Former inmates who receive social support have better mental health, study finds
March 22, 2019 - Nanofibrous membrane could enhance periodontal tissue regeneration
March 22, 2019 - Anti-vaxxer Italian leader down with chickenpox
March 22, 2019 - Servier collaborates with Harvard researchers to fight metabolic diseases
March 22, 2019 - National Eating Disorders Association
March 22, 2019 - Pumping up red blood cell production
March 22, 2019 - Excessive phosphate fertilizer may hurt plants by altering microbial composition in soil
March 22, 2019 - Medical marijuana laws could be improving older Americans’ health, study suggests
March 22, 2019 - Study indicates the benefits of stopping aspirin in heart attack patients
March 22, 2019 - Deep brain stimulation offers significant relief for patients with treatment-resistant depression
March 22, 2019 - Mental health problems in young adults on the rise
March 22, 2019 - Innovative membrane offers a viable solution for periodontitis
March 22, 2019 - The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
March 22, 2019 - insulin therapy: MedlinePlus Medical Encyclopedia
March 22, 2019 - Guidelines on the use of genetic testing in psychiatry
March 22, 2019 - Aspiring Doctors Seek Advanced Training In Addiction Medicine
March 22, 2019 - A change in focus could enable the development of new treatments for Alzheimer’s disease
March 22, 2019 - A new way to visualize the immune cell “landscape” of bowel cancer tumors
March 22, 2019 - Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia
March 22, 2019 - Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Study provides new insight into blood cell and immune cell production
IDT to demonstrate CRISPR expertise at European-focused events

IDT to demonstrate CRISPR expertise at European-focused events

image_pdfDownload PDFimage_print

As an advocate for the genomics age, Integrated DNA Technologies (IDT), will showcase its renowned CRISPR expertise at a series of European-focused events.

The genomics solution provider is well-known across the United States for its innovative nucleic acid-based products including oligonucleotides and PCR solutions, genes and gene fragments, NGS, functional genomics and CRISPR genome editing.

In order to increase the accessibly of its extensive CRISPR range of solutions to European markets, the company will be attending the Precision CRISPR Drug Discovery & Gene Therapy Europe Congress in London, October 22-24th and at the 4th Annual Genome Editing Congress, also in London on the 8-9th November 2018.

Delegates at these shows will have the opportunity to discover IDT’s range of solutions and benefit from the company’s expertise at booth and via various presentations.

IDT’s ethos is centered around advocating for researchers in the genomics age and has an extensive R&D program dedicated to developing the best possible genomics tools.

The CRISPR range of solutions is fully comprehensive and has been developed through rigorous research of each component of the CRISPR-driven, double-stranded break generation, critical for gene disruption and DNA insertion by homologous recombination.

The range includes an optimized Alt-R CRISPR-Cas9 system that outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.

This system features a novel HiFi Cas9 nuclease, Alt-R HiFi Cas9 Nuclease V3, that delivers highly efficient genome editing with reduced off-target effects, even in primary cells.

The enzyme has been recently described in a Nature Medicine paper in collaboration with  Dr. Matthew Porteus’ research team from Stanford University which demonstrated the robust on-target editing and minimal off-target cleavage achieved by HiFi Cas9 at therapeutically relevant loci, in hard-to-edit human hematopoietic stem and progenitor cells.

In addition, IDT provides an Alt-R CRISPR-Cas12a (Cpf1) system, opening up CRISPR editing to additional areas in genomes, guide RNA (gRNA) design tools and NGS solutions for analysis of CRISPR editing events.

The systems offer all the necessary tools and reagents for CRISPR experiments from design to analysis, including design tools, nucleases, nickases, recently-released CRISPR-Cas9 XTcrRNA, single guide RNA (sgRNA), tracrRNA, a new homology-driven repair (HDR) enhancer, electroporation enhancers, controls, and expression plasmids.

As well as off-the shelf solutions, IDT also offers custom solutions providing custom libraries, other CRISPR enzymes, formulations, and other CRISPR tools.

For those unable to attend the shows, or for more information, researchers can access IDT’s expertise by attending a webinar titled ‘Increasing genome editing efficiency and specificity with optimized CRISPR-Cas9 guide RNAs’ on Wednesday, October 24th 2018, 4pm CET.

Ashley Jacobi, Senior Staff Scientist in the Molecular Genetics Research and Development group at IDT, will compare the on-target and off-target editing events observed with different gRNA formats in transformed and primary cell lines, and provide guidelines on when to use each gRNA in the context of Cas9 source (plasmid, mRNA, ribonucleoprotein complex) and cell type.

IDT’s DECODED online newsletter also provides a wealth of useful educational information on CRISPR, including recorded webinars.

Tagged with:

About author

Related Articles